Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
110.75
-0.07 (-0.06%)
Aug 26, 2026, 8:52 AM EDT - Market open
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $743.37 million as of August 26, 2026. Its market cap has increased by 296.06% in one year.
Market Cap
743.37M
Enterprise Value
609.28M
1-Year Change
296.06%
Ranking
Category
Stock Price
$110.75
ChartMarket Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $743.37M, an increase of 169.19%. That is a compound annual growth rate of 15.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 743.37M | 70.35% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 782.27M |
| BridgeBio Oncology Therapeutics | 751.23M |
| Allogene Therapeutics | 749.72M |
| Tectonic Therapeutic | 737.21M |
| CytomX Therapeutics | 734.32M |
| Crescent Biopharma | 727.62M |
| Assembly Biosciences | 719.34M |
| Zevra Therapeutics | 714.98M |